A B S T R A C T PurposeFew data are available on breast cancer characteristics, treatment, and survival for women age 80 years or older. Patients and MethodsWe used the linked Surveillance, Epidemiology and End Results-Medicare data set from 1992 to 2003 to examine tumor characteristics, treatments (mastectomy, breast-conserving surgery [BCS] with radiation therapy or alone, or no surgery), and outcomes of women age 80 years or older (80 to 84, 85 to 89, Ն 90 years) with stage I/II breast cancer compared with younger women (age 67 to 79 years). We used Cox proportional hazard models to examine the impact of age on breast cancer-related and other causes of death. Analyses were performed within stage, adjusted for tumor and sociodemographic characteristics, treatments received, and comorbidities. ResultsIn total, 49,616 women age 67 years or older with stage I/II disease were included. Tumor characteristics (grade, hormone receptivity) were similar across age groups. Treatment with BCS alone increased with age, especially after age 80. The risk of dying from breast cancer increased with age, significantly after age 80. For stage I disease, the adjusted hazard ratio of dying from breast cancer for women age Ն 90 years compared with women age 67 to 69 years was 2.6 (range, 2.0 to 3.4). Types of treatments received were significantly associated with age and comorbidity, with age as the stronger predictor (26% of women age Ն 80 years without comorbidity received BCS alone or no surgery compared with 6% of women age 67 to 79 years). ConclusionWomen age Ն 80 years have breast cancer characteristics similar to those of younger women yet receive less aggressive treatment and experience higher mortality from early-stage breast cancer. Future studies should focus on identifying tumor and patient characteristics to help target treatments to the oldest women most likely to benefit.

Mesoporous materials are of technological interest because of their applications ranging from catalysts, molecular sieves, separation technology and gas sensors, to batteries and electronics. Here we demonstrate a synthetic methodology that allows us to create an ordered mesoporous nanocomposite with a crystalline oxide framework. We design a 'nanocrystal-glass' configuration to build a nanoarchitecture by means of surfactant-templated self-assembly followed by the controlled in-situ crystallization of materials. Functional nanocrystals are used as the building blocks of ordered mesopores, and the glass phase can act both as the 'glue' between nanocrystals and as a functionalized component in the composites. Specifically, we demonstrate this methodology for ordered mesoporous nanocomposites consisting of electrochemically active nanocrystals and semiconductive glass in the TiO2-P2O5-M(x)O(y) systems (where M is a metal ion). This approach could be applied to many other multicomponent oxides to fabricate mesoporous nanocomposites for numerous uses.